Enteric Nervous System Neurons in Parkinson's Disease

Introduction

Enteric Nervous System Neurons In Parkinson’S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The enteric nervous system (ENS) contains millions of neurons that control the gastrointestinal tract. In Parkinson’s disease, alpha-synuclein pathology and neurodegeneration extend to the ENS, often preceding motor symptoms by years or decades. ^{12007 - A primal role for the vagus nerve in the pathogenesis of Parkinson's disease2007 · PMID 17244656Open reference}

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: enteric neuron (source: Cell Ontology)

  • Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0007011)

• OBO Foundry (CL:0007011)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0007011)

• OBO Foundry (CL:0007011)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Normal Function

Enteric neurons control gut motility, secretion, and blood flow. They operate largely independently of the central nervous system but communicate bidirectionally via the vagus nerve. The myenteric plexus primarily regulates peristalsis, while the submucosal plexus controls secretion and mucosal blood flow.

Pathology in Parkinson’s Disease

Alpha-Synuclein Aggregation

• Lewy bodies and Lewy neurites containing phosphorylated alpha-synuclein have been observed in enteric neurons of PD patients [1]

• The prion-like spread hypothesis suggests that pathological alpha-synuclein may propagate from the gut to the brain via the vagus nerve [2]

• Studies show alpha-synuclein pathology in the ENS can precede motor symptoms by 10-20 years

Gastrointestinal Dysfunction

• Constipation is one of the most common prodromal symptoms of PD

• Delayed gastric emptying and colonic transit abnormalities are prevalent

• Enteric neuropathy may contribute to malabsorption and nutritional issues

Clinical Implications

Early Biomarker Potential

• Rectal biopsy can detect alpha-synuclein pathology in enteric neurons [3]

• Skin biopsy from sympathetic fibers provides similar diagnostic information

• ENS testing may enable early PD diagnosis before motor onset

Therapeutic Implications

• Gut-targeted interventions (probiotics, fecal microbiota transplantation) are being explored

• Preventing alpha-synuclein propagation from the ENS may slow disease progression

• Vagus nerve stimulation affects both gut and brain function

Research Models

• iPSC-derived enteric neurons: Patient-specific models carrying PD mutations (LRRK2, GBA, SNCA)

• Animal models: Mouse models with alpha-synuclein overexpression show ENS pathology

• Organoid systems: Gut-brain axis organoids to study alpha-synuclein transmission

Background

The study of Enteric Nervous System Neurons In Parkinson’S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• NCBI Gene - Gene database

• UniProt - Protein database

Pathway Diagram

graph TD
    Parkinson["Parkinson"] -->|"associated with"| Aging["Aging"]
    Parkinson["Parkinson"] -->|"associated with"| Autophagy["Autophagy"]
    Parkinson["Parkinson"] -->|"associated with"| Als["Als"]
    Parkinson["Parkinson"] -->|"therapeutic target"| Blood_Brain_Barrier["Blood-Brain Barrier"]
    Parkinson["Parkinson"] -->|"associated with"| Multiple_Sclerosis["Multiple Sclerosis"]
    Parkinson["Parkinson"] -->|"associated with"| Oxidative_Stress["Oxidative Stress"]
    Parkinson["Parkinson"] -->|"associated with"| Alzheimer["Alzheimer"]
    Parkinson["Parkinson"] -->|"associated with"| Apoptosis["Apoptosis"]
    Parkinson["Parkinson"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
    Parkinson["Parkinson"] -->|"therapeutic target"| Oxidative_Stress["Oxidative Stress"]
    Parkinson["Parkinson"] -->|"associated with"| Dementia["Dementia"]
    Parkinson["Parkinson"] -->|"therapeutic target"| Autophagy["Autophagy"]
    style Parkinson fill:#ef5350,stroke:#333,color:#e0e0e0
    style Aging fill:#ef5350,stroke:#333,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Als fill:#ef5350,stroke:#333,color:#e0e0e0
    style Blood_Brain_Barrier fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#e0e0e0
    style Oxidative_Stress fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
    style Apoptosis fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#333,color:#e0e0e0
    style Dementia fill:#ef5350,stroke:#333,color:#e0e0e0

Pathway Diagram

The following diagram shows the key molecular relationships involving Enteric Nervous System Neurons in Parkinson’s Disease discovered through SciDEX knowledge graph analysis:

graph TD
    PINK1["PINK1"] -->|"activates"| Parkinson["Parkinson"]
    NRF2["NRF2"] -->|"therapeutic target"| Parkinson["Parkinson"]
    Huntington["Huntington"] -->|"associated with"| Parkinson["Parkinson"]
    PTEN["PTEN"] -->|"activates"| Parkinson["Parkinson"]
    PARKIN["PARKIN"] -->|"associated with"| Parkinson["Parkinson"]
    DNA["DNA"] -->|"therapeutic target"| Parkinson["Parkinson"]
    Cancer["Cancer"] -->|"associated with"| Parkinson["Parkinson"]
    Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"] -->|"associated with"| Parkinson["Parkinson"]
    GENES["GENES"] -->|"activates"| Parkinson["Parkinson"]
    GENES["GENES"] -->|"therapeutic target"| Parkinson["Parkinson"]
    NRF2["NRF2"] -->|"activates"| Parkinson["Parkinson"]
    GENES["GENES"] -->|"regulates"| Parkinson["Parkinson"]
    Neuroinflammation["Neuroinflammation"] -->|"associated with"| Parkinson["Parkinson"]
    GENES["GENES"] -->|"associated with"| Parkinson["Parkinson"]
    PINK1["PINK1"] -->|"regulates"| Parkinson["Parkinson"]
    style PINK1 fill:#ce93d8,stroke:#333,color:#000
    style Parkinson fill:#ef5350,stroke:#333,color:#000
    style NRF2 fill:#ce93d8,stroke:#333,color:#000
    style Huntington fill:#ef5350,stroke:#333,color:#000
    style PTEN fill:#ce93d8,stroke:#333,color:#000
    style PARKIN fill:#ce93d8,stroke:#333,color:#000
    style DNA fill:#ce93d8,stroke:#333,color:#000
    style Cancer fill:#ef5350,stroke:#333,color:#000
    style Amyotrophic_Lateral_Sclerosis fill:#ef5350,stroke:#333,color:#000
    style GENES fill:#ce93d8,stroke:#333,color:#000
    style Neuroinflammation fill:#ef5350,stroke:#333,color:#000